Translational research in medication development for nicotine dependence
- 1 September 2007
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 6 (9) , 746-762
- https://doi.org/10.1038/nrd2361
Abstract
A major obstacle to the development of medications for nicotine dependence is the lack of animal and human laboratory models with sufficient predictive clinical validity to support the translation of knowledge from laboratory studies to clinical research. This Review describes the animal and human laboratory paradigms commonly used to investigate the pathophysiology of nicotine dependence, and proposes how their predictive validity might be determined and improved, thereby enhancing the development of new medications.Keywords
This publication has 260 references indexed in Scilit:
- Cocaine and Pavlovian fear conditioning: Dose–effect analysisBehavioural Brain Research, 2007
- Modeling the effect of alcohol on smoking lapse behaviorPsychopharmacology, 2006
- Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in ratsSynapse, 2003
- Increased GABA neurotransmission via administration of gamma-vinyl GABA decreased nicotine self-administration in the ratSynapse, 2002
- Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversiblePharmacology Biochemistry and Behavior, 1996
- Analog of neuropeptide FF attenuates morphine abstinence syndromePeptides, 1991
- Mecamylamine increases nicotine preference and attenuates nicotine discriminationPharmacology Biochemistry and Behavior, 1989
- Nicotine maintains robust self-administration in rats on a limited-access schedulePsychopharmacology, 1989
- Pharmacologic characterization of nicotine-induced conditioned place preferencePharmacology Biochemistry and Behavior, 1985
- Neurochemical modulation of sensory-motor reactivity: Acoustic and tactile startle reflexesNeuroscience & Biobehavioral Reviews, 1980